狗多中心淋巴瘤:诊断,治疗和预后见解
Michelle do Carmo Pereira Rocha1, Diana Araújo2,3, Fátima Carvalho2
1Department of Small Animal Clinic and Surgery, School of Agricultural and Veterinary Sciences, São Paulo State University (UNESP) "Júlio de Mesquita Filho", Jaboticabal 01049-010, SP, Brazil.
Animals : an open access journal from MDPI
|February 13, 2025
概括
狗多中心淋巴瘤是狗中常见的B细胞癌,与人类的非霍奇金淋巴瘤有相似之处.
科学领域:
- 兽医瘤学 兽医瘤学
- 比较病理学比较病理学
背景情况:
- 淋巴瘤是狗中流行的一种癌症,占所有犬类瘤的24%和血液性恶性瘤的85%.
- 多中心淋巴瘤占犬类淋巴瘤的84%,B细胞起源占60-80%.
- 由于共享的特征,狗可以作为研究人类非霍奇金淋巴瘤的有价值模型.
研究的目的:
- 审查当前关于犬多中心淋巴瘤的知识.
- 突出诊断,治疗和预后因素的重要性.
- 支持开发个性化和有效的疗法,以增加存活率.
主要方法:
- 本综述综合了有关犬类多中心淋巴瘤的现有文献.
- 收集了有关诊断标准,治疗选择和预后指标的信息.
- 讨论了与人类非霍奇金淋巴瘤的比较分析.
主要成果:
- 组织学等级,结构和免疫表型对于诊断和预后至关重要.
- 了解预后因素是制定定制治疗策略的关键.
- 狗多中心淋巴瘤研究可以为人类淋巴瘤研究提供信息.
结论:
- 准确的诊断和对预后因素的理解对于有效的犬类淋巴瘤治疗至关重要.
- 对治疗反应的进一步研究可以提高受影响狗的存活率.
- 狗模型为人类淋巴瘤的发病和治疗提供了重要的见解.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...